Astrantus »

Tandem Diabetes Care shares owned by Astrantus

Quarter-by-quarter ownership of Tandem Diabetes Care (TNDM) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $222k 1.9k 116.17

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Tandem Diabetes Care

BlackRock
Vanguard Group
Capital World Investors
UBS Group
State Street Corporation
Arrowpoint Asset Management
Fred Alger Management
Bellevue Group
Jennifer Ranahan
Geode Capital Management
Millennium Management
Champlain Investment Partners
Jennison Associates
Stephens Investment Management Group
Divisadero Street Capital Management

View all funds holding Tandem Diabetes Care